Table: q1_q4_2021_prescription_drug_wac_increases , manufacturer_name like W*

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  *

oshpd_id manufacturer_name date_reported ndc_number drug_product_description wac_effective_date wac_increase_amount wac_after_increase patent_expiration_date drug_source_type unit_sales_volume_in_us unit_sales_volume_non_public_indicator cost_increase_factors cost_increase_factors_non_public_indicator change_improvement_description change_improvement_non_public_indicator acquisition_date company_acquired_from acquisition_price acquisition_price_non_public_indicator acquisition_price_comment wac_at_acquisition wac_year_prior_to_acquisition year_drug_introduced_to_market wac_at_intro_to_market supporting_documents general_comments
Rx0000065 West Therapeutic Development, LLC 12/31/2021 71500011001 Lazanda® 100 mcg (fentanyl nasal spray) CII, 1 bottle (contains 8 metered dose sprays) 12/01/2021 84.12 1018.82 01/26/2032 Single Source Drug None 1 Market Conditions and increase in REM fees None NA None 11/01/2018 Assertio Therapeutics None 1 No comment. 752.57 665.74 2013 302.48 None None
Rx0000065 West Therapeutic Development, LLC 12/31/2021 71500014001 Lazanda® 400 mcg (fentanyl nasal spray) CII, 1 bottle (contains 8 metered dose sprays) 12/01/2021 134.15 1624.65 01/26/2032 Single Source Drug None 1 Market Conditions and increase in REM fees None NA None 11/01/2018 Assertio Therapeutics None 1 No comment. 1100.08 1061.60 2013 432.48 None None
Rx0000065 West Therapeutic Development, LLC 12/31/2021 71500000110 Subsys®™ 100 mcg (fentanyl sublingual spray) CII, 10 units / carton 12/01/2021 63.26 766.31 04/27/2030 Single Source Drug None 1 Market Conditions and increase in REM fees None NA None 09/26/2019 Insys Therapeutics None 1 No comment. 644.99 589.00 2014 309.99 None None
Rx0000065 West Therapeutic Development, LLC 12/31/2021 71500001215 Subsys®™ 1200 mcg (fentanyl sublingual spray) CII – 2 x 600 mcg, 30 units / carton 12/01/2021 504.92 6115.91 04/27/2030 Single Source Drug None 1 Market Conditions and increase in REM fees None NA None 09/26/2019 Insys Therapeutics None 1 No comment. 5147.64 4701.00 2014 2213.70 None None
Rx0000065 West Therapeutic Development, LLC 12/31/2021 71500001615 Subsys®™ 1600 mcg (fentanyl sublingual spray) CII – 2 x 800 mcg, 30 units / carton 12/01/2021 631.01 7642.22 04/27/2030 Single Source Drug None 1 Market Conditions and increase in REM fees None NA None 09/26/2019 Insys Therapeutics None 1 No comment. 6432.30 5874.30 2014 2727.00 None None
Rx0000065 West Therapeutic Development, LLC 12/31/2021 71500000230 Subsys®™ 200 mcg (fentanyl sublingual spray) CII, 30 units / carton 12/01/2021 250.64 3034.39 04/27/2030 Single Source Drug None 1 Market Conditions and increase in REM fees None NA None 09/26/2019 Insys Therapeutics None 1 No comment. 2553.98 2332.50 2014 1174.50 None None
Rx0000065 West Therapeutic Development, LLC 12/31/2021 71500000430 Subsys®™ 400 mcg (fentanyl sublingual spray) CII, 30 units / carton 12/01/2021 379.91 4600.17 04/27/2030 Single Source Drug None 1 Market Conditions and increase in REM fees None NA None 09/26/2019 Insys Therapeutics None 1 No comment. 3871.87 3536.10 2014 1704.90 None None
Rx0000065 West Therapeutic Development, LLC 12/31/2021 71500000630 Subsys®™ 600 mcg (fentanyl sublingual spray) CII, 30 units / carton 12/01/2021 504.92 6115.91 04/27/2030 Single Source Drug None 1 Market Conditions and increase in REM fees None NA None 09/26/2019 Insys Therapeutics None 1 No comment. 5147.64 4701.00 2014 2213.70 None None
Rx0000065 West Therapeutic Development, LLC 12/31/2021 20482000830 Subsys®™ 800 mcg (fentanyl sublingual spray) CII, 30 units / carton 12/01/2021 631.01 7642.22 04/27/2030 Single Source Drug None 1 Market Conditions and increase in REM fees None NA None 09/26/2019 Insys Therapeutics None 1 No comment. 6432.30 5874.30 2014 2904.39 None None